The antibiotic resistance crisis is a growing global health threat, endangering the effectiveness of antibiotics that have saved millions of lives. This article discusses the causes and threats of the crisis, with Part 2 focusing on strategies to manage it and new treatments for bacterial infections. Antibiotics were first used in the 1940s and have since transformed medicine, but their overuse and misuse, along with a lack of new drug development due to economic and regulatory challenges, have led to the rise of resistant bacteria. The Centers for Disease Control and Prevention (CDC) has classified several bacteria as urgent, serious, or concerning threats, placing a significant burden on the U.S. healthcare system. The history of antibiotics began with the discovery of penicillin in 1928, and since then, antibiotics have saved countless lives. However, resistance has emerged to nearly all antibiotics, with examples including MRSA and vancomycin-resistant enterococci. Overuse of antibiotics, inappropriate prescribing, and extensive agricultural use have all contributed to the crisis. The pharmaceutical industry has largely stopped developing new antibiotics due to economic and regulatory barriers, leading to a lack of new treatments. Regulatory challenges also hinder the development and approval of new antibiotics. Antibiotic-resistant infections are widespread, with serious consequences for patients and the healthcare system. They cause significant clinical and economic burdens, including increased hospital stays, higher costs, and mortality. The crisis is exacerbated by the spread of drug-resistant bacteria such as MRSA, VRE, and CRE, which are difficult to treat. The CDC has identified several bacteria as major threats, including drug-resistant strains of Streptococcus pneumoniae, Mycobacterium tuberculosis, and Neisseria gonorrhoeae. The crisis requires coordinated efforts to implement new policies, renew research, and develop new treatments. The article concludes that without action, the antibiotic resistance crisis will continue to threaten global health.The antibiotic resistance crisis is a growing global health threat, endangering the effectiveness of antibiotics that have saved millions of lives. This article discusses the causes and threats of the crisis, with Part 2 focusing on strategies to manage it and new treatments for bacterial infections. Antibiotics were first used in the 1940s and have since transformed medicine, but their overuse and misuse, along with a lack of new drug development due to economic and regulatory challenges, have led to the rise of resistant bacteria. The Centers for Disease Control and Prevention (CDC) has classified several bacteria as urgent, serious, or concerning threats, placing a significant burden on the U.S. healthcare system. The history of antibiotics began with the discovery of penicillin in 1928, and since then, antibiotics have saved countless lives. However, resistance has emerged to nearly all antibiotics, with examples including MRSA and vancomycin-resistant enterococci. Overuse of antibiotics, inappropriate prescribing, and extensive agricultural use have all contributed to the crisis. The pharmaceutical industry has largely stopped developing new antibiotics due to economic and regulatory barriers, leading to a lack of new treatments. Regulatory challenges also hinder the development and approval of new antibiotics. Antibiotic-resistant infections are widespread, with serious consequences for patients and the healthcare system. They cause significant clinical and economic burdens, including increased hospital stays, higher costs, and mortality. The crisis is exacerbated by the spread of drug-resistant bacteria such as MRSA, VRE, and CRE, which are difficult to treat. The CDC has identified several bacteria as major threats, including drug-resistant strains of Streptococcus pneumoniae, Mycobacterium tuberculosis, and Neisseria gonorrhoeae. The crisis requires coordinated efforts to implement new policies, renew research, and develop new treatments. The article concludes that without action, the antibiotic resistance crisis will continue to threaten global health.